FFN UK hip fracture review meeting at Wolfson College, Oxford on 8 May 2019.
This multidisciplinary meeting, supported by the BOA, will bring together the leading experts from orthopaedics, geriatrics, anaesthesia, nursing, physiotherapy, occupational therapy, rehabilitation and secondary fracture prevention. However, the emphasis is on discussion and shared-learning, so please bring along your own experiences, suggestions and questions.
The number of places is limited to 120, so please book early by contacting:
oxfordtrauma@ndorms.ox.ac.uk
Priority will be given to ‘teams’ of attendees i.e.…
Read more of this article
In early February, ARMA was one of 55 signatories to an open letter published in The Times newspaper from the Association of Directors of Public Health. The letter argued that public health should be a priority in the Spending Review.
Versus Arthritis is excited to report that over 1,000 people have answered the survey on aids and adaptations.
Prevention seems to have been the theme of my February. The possibility that a lot of the pain and disability of MSK conditions might be prevented, and that this is being taken seriously is an exciting prospect. Even where the conditions can’t be prevented, good self-management support can make a big difference to the impact of the condition. The Government is clear that the future sustainability of the NHS depends on prevention, and that it wants to improve healthy life expectancy by at least five extra years, by 2035.… 
We all know that MSK is one of the two biggest causes of sickness absence in the UK. It’s perhaps no surprise that this is even more true in the construction sector. Every year, occupational ill‐health costs construction employers £848million in reduced productivity, sick pay, cover for absence and replacing staff who leave because of ill health. 
ARMA has welcomed the inclusion of references to MSK in the NHS Long Term Plan. The real challenge is how to implement this in the local NHS plans. ARMA has set out the “
FOREUM – Foundation for Research in Rheumatology – announces a programme to support innovative concepts to improve the diagnosis and treatment of Rheumatic Musculoskeletal Diseases (RMDs). This programme is designed as an open research call seeking for the best and most visionary approaches to better understand RMDs and to improve the life of patients with RMDs.
